121 related articles for article (PubMed ID: 6324851)
1. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
[TBL] [Abstract][Full Text] [Related]
2. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
4. Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
Yamamoto T; Yamamoto S; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
J Biol Chem; 1983 Dec; 258(23):14173-7. PubMed ID: 6196360
[TBL] [Abstract][Full Text] [Related]
5. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
6. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
Degerman E; Belfrage P; Newman AH; Rice KC; Manganiello VC
J Biol Chem; 1987 Apr; 262(12):5797-807. PubMed ID: 3032944
[TBL] [Abstract][Full Text] [Related]
7. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
Bode DC; Kanter JR; Brunton LL
Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
[TBL] [Abstract][Full Text] [Related]
8. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
9. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
10. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
Yamamoto T; Yamamoto S; Manganiello VC; Vaughan M
Arch Biochem Biophys; 1984 Feb; 229(1):81-9. PubMed ID: 6322693
[TBL] [Abstract][Full Text] [Related]
11. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
Whalin ME; Strada SJ; Thompson WJ
Biochim Biophys Acta; 1988 Oct; 972(1):79-94. PubMed ID: 2846074
[TBL] [Abstract][Full Text] [Related]
12. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
Pichard AL; Cheung WY
J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
Martins TJ; Mumby MC; Beavo JA
J Biol Chem; 1982 Feb; 257(4):1973-9. PubMed ID: 6276403
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
Manganiello V; Degerman E; Elks M
Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
[No Abstract] [Full Text] [Related]
16. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
17. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
Gardner EA; Thompson WJ; Strada SJ; Stancel GM
Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
[TBL] [Abstract][Full Text] [Related]
18. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
Rascón A; Lindgren S; Stavenow L; Belfrage P; Andersson KE; Manganiello VC; Degerman E
Biochim Biophys Acta; 1992 Mar; 1134(2):149-56. PubMed ID: 1313303
[TBL] [Abstract][Full Text] [Related]
20. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
